Revixia Life Sciences

Revixia Life Sciences is a biotech company developing Salvinorin A (salvia) for substance use disorders (SUD), treatment-resistant depression (TRD), and pain.


Revixia is one of the few companies seeking to develop Salvinorin A for a host of mental disorders. The main benefit noted by Revixia is the shorter duration of salvia (SalA) in comparison to other psychedelics.

The company is a subsidiary of atai Life Sciences.

Company Information

Revixia Life Sciences Website

June, 2021


B2C Biotech

Compounds of Interest
Salvia Divinorum

Topics of Interest
Depression Addiction Pain Treatment-Resistant Depression

Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office Berlin, Germany